Reporting, handling, and interpretation of time-varying drug treatments in observational studies using routinely collected healthcare data.

Wen WangQiao HeJiayue XuMei LiuMingqi WangQianrui LiXia ZhangYunxiang HuangYuanjin ZhangLing LiKang ZouGuowei LiKevin LuPei GaoFeng ChenJeff Jianfei GuoMin YangXin Sun

Published in: Journal of evidence-based medicine (2023)

Among observational studies using RCD, the underreporting about the presence and methods for handling time-varying treatments was largely common. The potential biases due to time-varying treatments have frequently been disregarded. Collaborative endeavors are strongly needed to enhance the prevailing practices.

Keyphrases

healthcare
primary care
adverse drug
electronic health record
quality improvement
big data
risk assessment
social media
human health